Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04LRA
|
|||
| Former ID |
DNC001215
|
|||
| Drug Name |
Rimantadine isomer 2
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2], [3] | |
| SuperDrug ATC ID |
J05AC02
|
|||
| SuperDrug CAS ID |
cas=013392284
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Influenza M2 protein (Influ M) | Target Info | Inhibitor | [1], [2], [3] |
| WikiPathways | Influenza Life Cycle | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Antiviral agents active against influenza A viruses. Nat Rev Drug Discov. 2006 Dec;5(12):1015-25. | |||
| REF 2 | Heterocyclic rimantadine analogues with antiviral activity. Bioorg Med Chem. 2003 Dec 1;11(24):5485-92. | |||
| REF 3 | Are the 2-isomers of the drug rimantadine active anti-influenza A agents Antivir Chem Chemother. 2003 May;14(3):153-64. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.